(Press-News.org) The new Global Precipitation Measurement Core Observatory satellite is now in the hands of the engineers who will fly the spacecraft and ensure the steady flow of data on rain and snow for the life of the mission. The official handover to the Earth Science Mission Operations team at NASA's Goddard Space Flight Center in Greenbelt, Maryland, on May 29, marked the end of a successful check-out period.
The Global Precipitation Measurement (GPM) mission is a joint mission between NASA and the Japan Aerospace Exploration Agency. Its Core Observatory launched on Feb. 27, 2014, from Tanegashima Space Center in Japan. The satellite's two science instruments collect observations of rainfall and snowfall worldwide. Since launch, the satellite has gone through a thorough check-out of all its systems and reached its final orbit of 253 miles (407 kilometers) above Earth's surface.
"Commissioning has gone very well," said Mission Systems Engineer David Ward of NASA Goddard at GPM's Post-Launch Acceptance Review on May 15. "The issues that have occurred have been relatively minor. We're in very good shape."
The check-out period is like taking a new car out on a road trip – the engineers in the driver's seat learn how it handles and make adjustments to find the "sweet spots" for smooth flying and data collection. In the first weeks after launch the Flight Operations Team at Goddard, supported by the engineers who built the spacecraft, turned on spacecraft systems and ran them through normal procedures.
The team turned on both science instruments a few days after launch: the GPM Microwave Imager on March 1, and the Dual-frequency Precipitation Radar on March 2. Two weeks after launch, both instruments were collecting data and the team had begun calibration procedures to ensure that the data returned is as accurate as possible.
"We're doing really well," said Erich Stocker, GPM deputy project scientist and project manager for the Precipitation Processing System at Goddard, which handles data for GPM and its predecessor satellite, the Tropical Rainfall Measuring Mission (TRMM). "GMI is the best calibrated radiometer out of the box that we've ever had. And DPR is well-calibrated for this stage," he said, noting that the instrument can pick up weather elements, like classic thunderstorm anvil-shaped clouds, which TRMM could not.
A series of propulsion burns in March and early April took the Core Observatory into its final orbit at 253 miles. At that altitude, however, drag is still a problem – a very thin layer of atmosphere still exists, which can slow down a quickly moving satellite with two extended solar arrays. In low Earth orbit, slowing down means losing altitude. To counteract the drag, the thrusters had a planned burn every week to maintain speed and altitude. After evaluating how well the solar arrays were collecting power – very well – the flight team made minute adjustments to the angle of the arrays to reduce drag, reducing the need for altitude maintenance burns to every other week.
Altitude adjustments are one part of the Core Observatory's new routine, which also includes retrieving housekeeping data on the satellite systems and maintaining contact with NASA's communications satellites for speedier data downlinks. And, approximately every 40 days, moving in the same orbit direction, the team flips the spacecraft front-to-back. Due to GPM's inclined orbit 65 degrees from the equator, the spacecraft has a varying angle to the sun. The reversal of its orientation keeps the sun on the appropriate side of the spacecraft and prevents overheating.
Final tweaks and validation of the science data will continue through the summer, and the Precipitation Processing System will continue to streamline its production of multiple kinds of datasets, from the Core Observatory's individual 90-minute orbits to combining data with other satellites into global precipitation maps. GPM data will be available to the public by September 2014.
INFORMATION:
New NASA/JAXA precipitation satellite passes check-out, starts mission
2014-05-30
ELSE PRESS RELEASES FROM THIS DATE:
Wallow Fire study suggests there may be multiple paths to fuel reduction in the WUI
2014-05-30
Conservative fuel treatments designed to reduce fire severity while still providing forest cover and wildlife habitat worked equally as well as more intensive treatments in allowing for the protection of homes during the 2011 Wallow Fire, a study published in the journal Forest Ecology and Management has found. The distance into the treated area where fire severity was reduced varied, however, between these different thinning approaches where fuels were reduced. The findings suggest that there may be multiple paths to fuel treatment design around the wildland-urban interface ...
A first for NASA's IRIS: Observing a gigantic eruption of solar material
2014-05-30
VIDEO:
A coronal mass ejection burst off the side of the sun on May 9, 2014. The giant sheet of solar material erupting was the first CME seen by NASA's Interface...
Click here for more information.
A coronal mass ejection, or CME, surged off the side of the sun on May 9, 2014, and NASA's newest solar observatory caught it in extraordinary detail. This was the first CME observed by the Interface Region Imaging Spectrograph, or IRIS, which launched in June 2013 to peer into ...
Myriad presents data on BRACAnalysis CDx and HRD at 2014 ASCO meeting
2014-05-30
SALT LAKE CITY, Utah, May 30, 2014 – Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics, announced the presentation of new data at the American Society of Clinical Oncology (ASCO) meeting this week that supports the clinical efficacy of its BRACAnalysis CDx™ and HRD™ tests in predicting platinum based therapy response for breast cancer patients. Additionally, the company is providing an update on key commercial milestones that underscore its commitment to the field of companion diagnostics.
"Myriad is committed to advancing the science of companion ...
New method of wormlike motion lets gels wiggle through water
2014-05-30
Next time you spot an earthworm sliding through fresh dirt, take a closer look. What you're seeing is an organic movement called peristaltic locomotion that has been meticulously refined by nature.
Jarod Gregory, an undergraduate student in the University of Cincinnati's College of Engineering and Applied Science, used a worm's contracting and expanding motion to provide a way for gels to swim in water. This is a product of work by the interdisciplinary team consisting of Jarod Gregory, a chemical engineering major, and his two advisers, Lilit Yeghiazarian, assistant ...
New drug treatment helps prevent early menopause in breast cancer patients
2014-05-30
MAYWOOD, Ill. (May 30, 2014) – Among young women treated for breast cancer, one of the most distressing side effects of chemotherapy is early menopause. But a major clinical trial has found that the risk of early menopause can be significantly reduced by adding a drug called goserelin to the chemotherapy regimen. Also, women who took goserelin and wanted to have children were more likely to get pregnant and deliver a healthy baby.
Results were released during the 2014 American Society of Clinical Oncology 50th Annual Meeting in Chicago. Kathy Albain, MD, of Loyola University ...
Stopping statins may benefit terminally ill patients
2014-05-30
Results presented today at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) and June 6 at the European Association of Palliative Care Research Conference show that stopping statins for cholesterol management in the late stages of cancer or other terminal illnesses may offer quality-of-life and even life-extending benefits. The results highlight the larger question of when, if ever, it is appropriate in patients with life-limiting illnesses to discontinue medications prescribed for other conditions that will likely not lead to their death.
Researchers ...
Women with metastatic breast cancer can safely receive bisphosphonates less frequently, without comp
2014-05-30
CHICAGO – Women with metastatic breast cancer to the bone may be able to receive bisphosphonates, the bone-targeting class of drugs like zoledronic acid, less often after the first year of monthly administration. With that practice change, women may also reduce their risk of serious side effects, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.
The research was presented today on the press program of the American Society of Clinical Oncology 2014 Annual Meeting by MD Anderson's Gabriel Hortobagyi, MD, professor, Breast Medical ...
Phase I study of DMOT4039A in patients with pancreatic or ovarian cancer
2014-05-30
A study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) describes the results of a phase I clinical trial of the investigational agent DMOT4039A against pancreatic and ovarian cancers. In this early clinical trial with the goal of identifying possible risks and defining likely dosages, the drug was well tolerated and in some patients showed initial evidence of anti-cancer activity.
The drug is in fact a combination of a chemotherapeutic agent with an antibody, technically called an antibody-drug conjugate (ADC). Just as cells ...
Genetic profile predicts which bladder cancer patients will benefit from early chemotherapy
2014-05-30
CHICAGO, IL (May 30, 2014)—Three genetic changes can predict whether a patient will benefit from chemotherapy before surgery to remove bladder cancer, according to new findings presented by Fox Chase Cancer Center researchers during the 50th Annual Meeting of the American Society of Clinical Oncology.
During the study, 36 patients with muscle-invasive bladder cancer received chemotherapy before surgery, consisting of an accelerated regimen of methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC). By the time surgery rolled around, 14 patients appeared cancer-free. ...
For the first time in the lab, researchers see stem cells take key step toward development
2014-05-30
CHAMPAIGN, Ill. — The gap between stem cell research and regenerative medicine just became a lot narrower, thanks to a new technique that coaxes stem cells, with potential to become any tissue type, to take the first step to specialization. It is the first time this critical step has been demonstrated in a laboratory.
University of Illinois researchers, in collaboration with scientists at Notre Dame University and the Huazhong University of Science and Technology in China, published their results in the journal Nature Communications.
"Everybody knows that for an embryo ...